Spending by European consumers on over-the-counter medicines is forecast to exceed $20 billion this year, up 41% on spending in 1990, says a new study from James Dudley International.
This will represent a saving to European government health care schemes of over $9 billion, says the study, which is entitled The European Consumers' Usages and Attitudes to Self-Medication.
The study says about 25% of all European adults normally now choose to self-medicate for minor ailments rather than consult a doctor, while a further quarter tend not to treat at all. French, Spanish and German consumers are more likely than the British to consult their doctor for a minor ailment. The Swiss spend two and a half times the European average on OTC medicines, and Belgians spend twice as much, it says. Austrian, UK, Italian and Dutch consumers spend about 60% of the European average, while Poles and Hungarians spend one third.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze